Joel Greenblatt's position in 10x Genomics is currently worth $220 Thousand. That's 0.00% of their equity portfolio (1185th largest holding). The investor's estimated purchase price is $415 Thousand, resulting in a loss of 47%.
Avg closing price
Price range
Increased shares by 23.7% (+1.67 Thousand shares)
Q4 2023
Avg closing price
$43.51
Price range
$34.32
-
$57.55
Increased shares by 1.7% (+114 shares)
Q3 2023
Avg closing price
$52.02
Price range
$40.86
-
$62.98
Increased shares by 37.4% (+1.88 Thousand shares)
Q2 2023